Physician profile
Rita Sharma
NPI 1215035407
$4,165.09
in general payments reported to CMS, 2019-2025
24 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 87% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $195 · 2021: $604 · 2022: $1,064 · 2023: $553 · 2024: $159 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,032 · Food and Beverage: $958 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,032.37 |
| Food and Beverage | $958.18 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,583.08 | 2021-2025 | Altaviva, Interstim |
| Coloplast Corp | $700.68 | 2019-2025 | Supris |
| Astellas Pharma US INC | $417.37 | 2020-2025 | Veozah |
| Pfizer INC. | $237.27 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $187.96 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $183.70 | 2019-2023 | Orilissa |
| Myovant Sciences INC. | $141.13 | 2021-2022 | |
| Daiichi Sankyo INC. | $103.74 | 2019-2023 | Injectafer |
| Intuitive Surgical, INC. | $103.37 | 2025 | |
| Aspira Women'S Health INC | $98.88 | 2022-2023 | Ova1 |
| Ascend Therapeutics US, LLC | $91.06 | 2019-2023 | |
| Hologic Sales and Service, LLC | $67.76 | 2023-2025 | Acessa Provu System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Shield Therapeutics INC | $41.15 | 2023 | Accrufer |
| Boston Scientific Corporation | $26.74 | 2019 | |
| Avanos Medical | $24.59 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $24.15 | 2023 | Bd Onclarity |
| Amag Pharmaceuticals, INC. | $22.24 | 2019-2020 | |
| Glaxosmithkline, LLC. | $21.92 | 2025 | Trelegy Ellipta |
| Medline Industries LP | $18.51 | 2020 | |
| Alexion Pharmaceuticals, INC. | $15.37 | 2022 | |
| Novo Nordisk INC | $15.14 | 2025 | Wegovy |
| Exact Sciences Corporation | $14.12 | 2024 | Cologuard Collection Kit |
| Axonics, INC. | $12.61 | 2021 | |
| Therapeuticsmd, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.